Floatz logo

Chiglitazar

PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries

Shengjing HospitalPhase 2/3Active
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
53/ 100
Competitive Position
89/ 100

Competitive context

65 Active assets in the PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries cohort.

Asset / SponsorPhaseRating
Hcg
Eman Basuni Ebrahim Mowad
Phase 4BBB
Liraglutide
Peking University Third Hospital
Phase 4BBB
Semaglutide
Methodist Health System
Phase 4BBB
Drospirenone
Ege University
Phase 4BBB
FOLLITROPIN BETA
Universitair Ziekenhuis Brussel
Phase 4BBB

View all 50 →

Same molecule, other indications

Chiglitazar is also rated in:

ChiglitazarDormant
B
Indicative ·
61 / 100
View asset →
MetforminDormant
B
Indicative ·
61 / 100
View asset →
metabolic dysfunction-associated steatohepatitisDormant
CCC
Indicative ·
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →